NEPHROCARE Stock Overview
A healthcare provider, operates Nephro Care clinics for the treatment of kidney-related diseases.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nephro Care India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹333.20 |
| 52 Week High | ₹378.80 |
| 52 Week Low | ₹171.00 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 85.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEPHROCARE | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 17.3% | 2.0% | 2.8% |
| 1Y | n/a | 41.8% | 47.6% |
Return vs Industry: Insufficient data to determine how NEPHROCARE performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how NEPHROCARE performed against the Indian Market.
Price Volatility
| NEPHROCARE volatility | |
|---|---|
| NEPHROCARE Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: NEPHROCARE's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NEPHROCARE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Somnath Chakraborty | www.nephrocareindia.com |
Nephro Care India Limited, a healthcare provider, operates Nephro Care clinics for the treatment of kidney-related diseases. The company’s clinics offer medical services, such as kidney transplantation, diabetic kidney disease, hypertensive nephropathy, glomerular disease, ADPKD clinic, kidney stone, genetic kidney disease, cardiology, disease specific nutrition, diet consultation, lifestyle and yoga therapy, and online yoga consultation. It also provides outpatient services in the areas of nephrology, diabetology, cardiology, ophthalmology, and neurology.
Nephro Care India Limited Fundamentals Summary
| NEPHROCARE fundamental statistics | |
|---|---|
| Market cap | ₹5.65b |
| Earnings (TTM) | ₹19.42m |
| Revenue (TTM) | ₹170.93m |
282.8x
P/E Ratio32.1x
P/S RatioIs NEPHROCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEPHROCARE income statement (TTM) | |
|---|---|
| Revenue | ₹170.93m |
| Cost of Revenue | ₹61.65m |
| Gross Profit | ₹109.28m |
| Other Expenses | ₹89.86m |
| Earnings | ₹19.42m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.18 |
| Gross Margin | 63.93% |
| Net Profit Margin | 11.36% |
| Debt/Equity Ratio | 101.1% |
How did NEPHROCARE perform over the long term?
See historical performance and comparison